Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus
EK1 peptide is a membrane fusion inhibitor with broad-spectrum activity against human coronaviruses (CoVs). In the outbreak of COVID-19, we generated a lipopeptide EK1V1 by modifying EK1 with cholesterol, which exhibited significantly improved antiviral activity. In this study, we surprisingly found...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis Group
2021-01-01
|
| Серія: | Emerging Microbes and Infections |
| Предмети: | |
| Онлайн доступ: | https://www.tandfonline.com/doi/10.1080/22221751.2021.1917309 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|